-
Tata India Pharma & Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 11/07/25 )
NAV
₹30.34
Last change
₹-0.04 -0.0%
Fund Size (AUM)
1281.99 Cr
Performance
21.88% (5Y)
Fund Details
Tata India Pharma & Healthcare Fund Regular Growth
as of 11/07/25
AUM
1281.99 Cr
Expense Ratio
2.11 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K016A9
Fund Manager
Rajat Srivastava
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular Growth | 11.03% | 23.92% | 21.88% |
| Nifty Pharma TR INR | 19.26% | 27.0% | 22.17% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.17% |
Apollo Hospitals Enterprise Ltd |
7.19% |
Cipla Ltd |
5.76% |
Divi's Laboratories Ltd |
5.58% |
Aurobindo Pharma Ltd |
5.44% |
Fortis Healthcare Ltd |
5.3% |
Lupin Ltd |
4.58% |
Aster DM Healthcare Ltd Ordinary Shares |
4.45% |
Wockhardt Ltd |
3.67% |
Alkem Laboratories Ltd |
2.9% |
Sector Allocation
Healthcare |
96.43% |
Basic Materials |
2.54% |
Financial |
1.04% |
Asset Allocation
-
92%
Equity
-
8%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
24.45% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
23.98% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
23.98% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
21.72% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
22.02% (5Y)
-
-
UTI Healthcare Reg IDCW-P
Equity healthcare-
Returns
-
22.02% (5Y)
-
